Skip to main content
. 2023 Jun 26;129(3):511–520. doi: 10.1038/s41416-023-02312-z

Table 3.

Stratified analysis for gene-diabetes interactions for colorectal cancer that were statistically significant.

Primary GxE testing: rs3802177, chromosome 8, SLC30A8
AA AG GG per G allele stratified by diabetes
#cases /#controls OR (95% CI) p-value #cases /#controls OR (95% CI) p-value #cases /#controls OR (95% CI) p-value OR (95% CI) p-value
Diabetes = No 2605/3640 1.00 (Ref.) 11848/16321 1.00 (0.95–1.06) 9.3 × 10−01 13307/18333 1.01 (0.95–1.07) 8.5 × 10−01 1.00 (0.98–1.03) 8.2 × 10−01
Diabetes = Yes 300/227 1.62 (1.34–1.96) 7.5 × 10−07 1496/1285 1.42 (1.29–1.56) 1.2 × 10−12 1762/1694 1.23 (1.12–1.34) 7.5 × 10−06 0.87 (0.80–0.94) 5.4 × 10−04
OR for diabetes stratified by genotype 1.62 (1.34–1.96) 7.5 × 10−07 1.41 (1.3–1.54) 6.2 × 10−16 1.22 (1.13–1.31) 2.4 × 10−07
Secondary GxE testing: rs9526201, chromosome 13, LRCH1
GG GA AA per A allele stratified by diabetes
#cases /#controls OR (95% CI) p-value #cases /#controls OR (95% CI) p-value #cases /#controls OR (95% CI) p-value OR (95% CI) p-value
Diabetes = No 859/1342 1.00 (Ref.) 7958/11639 1.06 (0.96–1.17) 2.2 × 10−01 18943/25313 1.15 (1.05–1.27) 2.9 × 10−03 1.08 (1.05–1.11) 4.7 × 10−7
Diabetes = Yes 133/92 2.11 (1.56–2.83) 8.9 × 10−07 1068/902 1.62 (1.42–1.84) 7.5 × 10−13 2358/2212 1.3 (1.16–1.46) 1.8 × 10−09 0.85 (0.77–0.93) 5.9 × 10−4
OR for diabetes stratified by genotype 2.11 (1.56–2.83) 8.9 × 10−07 1.52 (1.38–1.68) 1.1 × 10−16 1.13 (1.06–1.21) 3.8 × 10−09

Number of case/control counts were calculated by imputed genotype probabilities. Analyses were adjusted for age at baseline, sex, study, genotyping platform, and the first three principal components.

Odds ratios (OR) and 95% confidence interval (CI) are shown for association of diabetes with colorectal cancer risk stratified by genotype (rs3802177 and rs9526201) and for association of genotype with colorectal cancer risk stratified by diabetes.